Patients living with lung diseases often experience restricted breathing which causes limited mobility and loss of regular activity. Alongside pharmacotherapies, promoting activity, can not only increase quality of life for a patient but also provide healthcare professionals with a cost-effective method of treatment. Activity can be promoted through informal increased activity for a patient in everyday life or through prescribed sessions of pulmonary rehabilitation. Despite evidence supporting the benefits of activity, it is an underused intervention. In the latest instalment of ERS Vision, experts discuss how activity can decrease hospital admissions and represent cost savings, while patients share their experiences of how physical activity has improved their quality of life.
European Respiratory Society launches its latest vision to support those with respiratory health difficulties throughout europe: encouraging patients to increase their levels of activity which is proven to improve lung health.
Share this post
Latest News posts
Vaccine Types
November 22, 2021
Vitamin D supplements
November 3, 2021
Herd immunity to COVID-19 – is it achievable?
October 28, 2021
Walk and paint yourself back to health & wellbeing
October 14, 2021
Antifungal Drug Pipeline
October 8, 2021
Is it COVID or just a cold?
September 24, 2021
World Sepsis Day 2021
September 13, 2021
Aspergillosis and Depression: A Personal Reflection
September 1, 2021
Therapeutic drug monitoring (TDM)
August 9, 2021
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video